Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04393753
Title Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1 (MERKLIN2)
Acronym MERKLIN2
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors 4SC AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
UZ Leuven Leuven Belgium Details
Bordeaux Hôpital Saint Andre Bordeaux France Details
Hôpital Ambroise Paré - Boulogne-Billancourt Boulogne-Billancourt France Details
CHU Nantes - Hotel Dieu Nantes France Details
Hôpital Saint-Louis Paris France Details
Universitätsklinikum Dresden Dresden Germany Details
Helios Klinikum Erfurt Erfurt Germany Details
Universitätsklinikum Essen Essen Germany Details
Universitätsklinikum Heidelberg Heidelberg Germany Details
Universitätsklinikum Schleswig-Holstein Kiel Kiel Germany Details
Universitätsklinikum Köln Köln Germany Details
Universitätsklinikum Leipzig Leipzig Germany Details
Universitätsklinikum Schleswig-Holstein, Campus Lübeck Lübeck Germany Details
Technische Universität München München Germany Details
Universitätsklinikum Tübingen Tübingen Germany Details
Instituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari Bari Italy Details
Istituto Nazionale Tumori Fondazione G.Pascale Naples Italy Details
IOV - Istituto Oncologico Veneto IRCCS Padova Italy Details
Fondazione del Piemonte per l'Oncologia Torino Italy Details
Netherlands Cancer Institute Amsterdam Amsterdam Netherlands Details
Academic Hospital Maastricht Maastricht Netherlands Details
Hospital Universitari Vall d'Hebron Barcelona Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field